We found that low expression of lnc021545 was closely associated with some clinical features (Table 1)—for example, tumor size (p = 0.0025), advanced TNM stage (p = 0.003), lymph node metastasis (p = 0.01), and HER-2 amplification (p = 0.012). This evidence concerns the gene ERBB2 and neoplasm.